1. Home
  2. ORMP vs EVG Comparison

ORMP vs EVG Comparison

Compare ORMP & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.11

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

HOLD

Current Price

$10.82

Market Cap

142.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORMP
EVG
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
142.9M
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
ORMP
EVG
Price
$4.11
$10.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
516.0K
33.5K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
6.51%
N/A
EPS Growth
412.50
N/A
EPS
0.91
N/A
Revenue
$2,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.45
N/A
Revenue Growth
49.25
N/A
52 Week Low
$1.98
$10.40
52 Week High
$5.19
$11.45

Technical Indicators

Market Signals
Indicator
ORMP
EVG
Relative Strength Index (RSI) 47.66 54.58
Support Level $3.69 $10.62
Resistance Level $4.22 $10.94
Average True Range (ATR) 0.28 0.10
MACD -0.06 0.01
Stochastic Oscillator 16.67 67.96

Price Performance

Historical Comparison
ORMP
EVG

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: